Stock grant boosts TechnipFMC (NYSE: FTI) director’s shareholdings

Rhea-AI Filing Summary

TechnipFMC plc director Sophie Zurquiyah Rousset reported an equity award. She acquired 3,259 ordinary shares on a grant basis, with a stated price of $0.00 per share, as a grant, award, or other acquisition.

The award is in the form of restricted stock units, each representing a contingent right to receive one ordinary share, scheduled to vest on February 16, 2027. Following this grant, she directly holds 66,237 ordinary shares of TechnipFMC.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zurquiyah Rousset Sophie

(Last) (First) (Middle)

C/O TECHNIPFMC PLC

HADRIAN HOUSE, WINCOMBLEE ROAD

(Street)

NEWCASTLE UPON TYNE X0 NE6 3PL

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TechnipFMC plc [ FTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/16/2026		A		3,259(1)	A	$0	66,237	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units, each of which represents a contingent right to receive one Ordinary Share, that will vest February 16, 2027.

Remarks:

	/s/ Lisa P. Wang, Attorney-In-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did TechnipFMC (FTI) director Sophie Zurquiyah Rousset report?

She reported receiving an equity award of 3,259 ordinary shares. The filing classifies it as a grant, award, or other acquisition, recorded at a price of $0.00 per share under a Form 4 insider transaction report.

How many TechnipFMC (FTI) shares were granted to Sophie Zurquiyah Rousset?

She was granted 3,259 ordinary shares through restricted stock units. Each restricted stock unit represents a contingent right to receive one ordinary share, increasing her direct holdings reported in the filing to a total of 66,237 ordinary shares.

What are the terms of the restricted stock units granted to TechnipFMC (FTI) director Sophie Zurquiyah Rousset?

The award consists of restricted stock units, each equal to one ordinary share. According to the disclosure, these units will vest on February 16, 2027, meaning the shares become deliverable to her on that future vesting date.

Did Sophie Zurquiyah Rousset buy TechnipFMC (FTI) shares on the market in this Form 4?

No, the Form 4 shows a grant, not an open-market purchase. The 3,259 ordinary shares were acquired as a grant or award at a reported price of $0.00 per share, reflecting compensation rather than a cash transaction.

What is Sophie Zurquiyah Rousset’s total TechnipFMC (FTI) share ownership after this grant?

After the reported grant, she directly owns 66,237 ordinary shares. This total includes the newly awarded 3,259 shares from the restricted stock unit grant disclosed in the Form 4 insider transaction report.

When will the restricted stock units granted to TechnipFMC (FTI) director vest?

The restricted stock units are scheduled to vest on February 16, 2027. At that time, each vested unit will entitle her to receive one ordinary share of TechnipFMC, as described in the accompanying footnote.